Table 2.
Number of participants for each lipid variable defined by reference values in idiopathic SSNHL patients and control subjects
Variable | Reference range | Number of subjects | р value 1 | |
---|---|---|---|---|
control subjects (n = 24) | idiopathic SSNHL patients (n = 27) | |||
TC, mmol/L a | < 5.2 | 0 | 4 (14.8) | 0.149 |
TG, mmol/L a | < 1.7 | 2 (8.3) | 7 (25.9) | 0.202 |
HDL-C, mmol/L a | < 1.0 | 1 (4.2) | 7 (25.9) | 0.081 |
LDL-C, mmol/L a | < 2.6 | 7 (29.2) | 13 (48.1) | 0.272 |
TC/HDL-C b[40] | < 4.5 | 3 (12.5) | 6 (22.2) | 0.689 |
apoA-I, mg/dL b[41] | > 120 | 7 (29.2) | 13 (48.1) | 0.272 |
apoB, mg/dL b[42] | < 120 | 2 (8.3) | 11 (40.7) | 0.020 |
apoB/apoA-I b[43] | < 0.9 | 4 (16.7) | 15 (55.6) | 0.010 |
apoE, mg/dL b[44] | > 2.7 | 13 (54.2) | 13 (48.1) | 0.882 |
AIP b[29] | < 0.11 | 1 (4.2) | 7 (25.9) | 0.081 |
ATH index b[30] | < 4.5 | 0 | 8 (29.6) | < 0.033 |